Dr. Yetter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5300 Memorial Dr
Two Rivers, WI 54241Phone+1 920-793-7300
Education & Training
Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996- Loyola University Medical CenterResidency, Internal Medicine, 1990 - 1993
University of Illinois College of MedicineClass of 1990
Certifications & Licensure
WI State Medical License 1996 - 2025
IL State Medical License 1990 - 1996- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Join now to see all
Publications & Presentations
PubMed
- 168 citationsHeparin‐induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institutionSucha Nand, Warren Wong, Benjamin Yuen, Andrew Yetter, Edwin Schmulbach
American Journal of Hematology. 1998-07-01 - 15 citationsInsulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.Shahab Uddin, Yetter A, Katzav S, Hofmann C, White Mf
Experimental Hematology. 1996-04-01 - 108 citationsThe type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2.Leonidas C. Platanias, Shahab Uddin, Andrew Yetter, Xiao Jian Sun, Morris F. White
The Journal of Biological Chemistry. 1996-01-05
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
